CBLLNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Ceribell, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$26.00+0.96 (+3.83%)
Close on Oct 19, 2026
- Market cap
- $988.83M
- P/E (TTM)
- –
- Dividend yield
- –
Ceribell, Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product revenue | $21.24M | $20.19M | $18.78M | $17.02M | $15.92M | $15.61M | $14.15M | $13.32M | $11.58M | $11.04M | $10.01M | $8.76M | 75.6% | +33.4% |
| Subscription revenue | $6.86M | $6.30M | $6.00M | $5.57M | $5.28M | $4.88M | $4.39M | $3.87M | $3.74M | $3.37M | $3.12M | $2.85M | 24.4% | +29.9% |
By region
From the segment and revenue-disaggregation notes of Ceribell's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.